Saved in:
| Main Authors: | Eleftheria A. Georgiou, Kalliopi Christopoulou, Amalia D. Kalampaliki, Aikaterini F. Giannopoulou, Eleftheria Chatziorfanou, Vivi Bafiti, Andreas Krämer, Athanasios Papakyriakou, Dimitrios J. Stravopodis, Stefan Knapp, Ioannis K. Kostakis |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | https://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/cmdc.70324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
by: Zheng Ma, et al.
Published: (2025)
by: Zheng Ma, et al.
Published: (2025)
In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
by: Frankie S. Mak, et al.
Published: (2026)
by: Frankie S. Mak, et al.
Published: (2026)
Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
by: Kelly A. McCarthy, et al.
Published: (2024)
by: Kelly A. McCarthy, et al.
Published: (2024)
Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy
by: Gaurav Sheth, et al.
Published: (2025)
by: Gaurav Sheth, et al.
Published: (2025)
An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
by: Yazhou Wang, et al.
Published: (2026)
by: Yazhou Wang, et al.
Published: (2026)
Preparation of Dearomatized p‐Coumaric Acid Derivatives as DNA Damage Response Inhibitors with Potent In Vitro Antitumor Effect
by: Laura Fási, et al.
Published: (2024)
by: Laura Fási, et al.
Published: (2024)
Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors
by: Cornelia Zumbrunn, et al.
Published: (2025)
by: Cornelia Zumbrunn, et al.
Published: (2025)
Design and Synthesis of Potent Ridaifen Analogues: Evaluation as Anticancer, 20S Proteasomal Inhibitors, and Antiebola Virus Agents through In vitro and In Silico Studies
by: Merna A. Vector, et al.
Published: (2025)
by: Merna A. Vector, et al.
Published: (2025)
Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors
by: Yaojia Li, et al.
Published: (2025)
by: Yaojia Li, et al.
Published: (2025)
Quinoline‐ and Pyrimidine‐based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPase
by: Stefan Paula, et al.
Published: (2024)
by: Stefan Paula, et al.
Published: (2024)
Cover Feature: An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors (ChemMedChem 6/2026)
by: Yazhou Wang, et al.
Published: (2026)
by: Yazhou Wang, et al.
Published: (2026)
Artificial Ion Transporters as Potent Therapeutics for Channelopathies
by: Wei Huang, et al.
Published: (2024)
by: Wei Huang, et al.
Published: (2024)
Front Cover: Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′‐ O ‐Benzylidene Acetal Side Chains as Potent α ‐Glucosidase Inhibitors (ChemMedChem 21/2025)
by: Yaojia Li, et al.
Published: (2025)
by: Yaojia Li, et al.
Published: (2025)
Diversity Oriented Synthesis of Novel Xanthones Reveal Potent Doxorubicin‐Inspired Analogs
by: Jonas W. Meringdal, et al.
Published: (2024)
by: Jonas W. Meringdal, et al.
Published: (2024)
Bushy‐Tailed Multicationic Quaternary Phosphonium Compounds: Potent Amphiphilic Disinfectants with Promising Therapeutic Indices
by: Diana Rachii, et al.
Published: (2024)
by: Diana Rachii, et al.
Published: (2024)
Sphaeropsidin A C15–C16 Cross‐Metathesis Analogues with Potent Anticancer Activity
by: Sachin B. Wagh, et al.
Published: (2024)
by: Sachin B. Wagh, et al.
Published: (2024)
Tryptophan‐Rich Short Peptide Amphiphile‐Mediated Synthesis of Silver Nanoparticles for Potent Antibacterial Applications
by: Govind Singh, et al.
Published: (2025)
by: Govind Singh, et al.
Published: (2025)
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
by: Trent D. Ashton, et al.
Published: (2024)
by: Trent D. Ashton, et al.
Published: (2024)
Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation Potential
by: Abdelsattar M. Omar, et al.
Published: (2025)
by: Abdelsattar M. Omar, et al.
Published: (2025)
Design and Synthesis of 2‐Nitroimidazole‐1,2,3‐triazole Sulfonamide Hybrids as Potent and Selective Anti‐Trypanosomatid Agents
by: Victória C. Tietz, et al.
Published: (2024)
by: Victória C. Tietz, et al.
Published: (2024)
CORRIGENDUM: Carboranes as Potent Phenyl Mimetics: A Comparative Study on the Reversal of ABCG2‐Mediated Drug Resistance by Carboranylquinazolines and Their Organic Isosteres
Published: (2024)
Published: (2024)
APH Inhibitors that Reverse Aminoglycoside Resistance in Enterococcus casseliflavus
by: Elise Kaplan, et al.
Published: (2025)
by: Elise Kaplan, et al.
Published: (2025)
The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy
by: Qiuying Nie, et al.
Published: (2024)
by: Qiuying Nie, et al.
Published: (2024)
Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors
by: Alisa Heuser, et al.
Published: (2024)
by: Alisa Heuser, et al.
Published: (2024)
The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design
by: Konstantina Nikovia, et al.
Published: (2026)
by: Konstantina Nikovia, et al.
Published: (2026)
Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
by: Alexander D. Landgraf, et al.
Published: (2025)
by: Alexander D. Landgraf, et al.
Published: (2025)
Binding‐Site Switch for Protein Kinase CK2 Inhibitors
by: Dylan Grenier, et al.
Published: (2025)
by: Dylan Grenier, et al.
Published: (2025)
Decoding Urease Inhibition: A Comprehensive Review of Inhibitor Scaffolds
by: Nuno Martinho, et al.
Published: (2026)
by: Nuno Martinho, et al.
Published: (2026)
Thiazole‐Based IL‐17 Inhibitors Discovered by Scaffold Morphing
by: Juraj Velcicky, et al.
Published: (2025)
by: Juraj Velcicky, et al.
Published: (2025)
Gram‐Scale Synthesis of an Arylsulfonamide‐Type Alkaline Phosphatase Inhibitor
by: Zsolt Rapi, et al.
Published: (2026)
by: Zsolt Rapi, et al.
Published: (2026)
Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
by: Nadiya Brovchenko, et al.
Published: (2025)
by: Nadiya Brovchenko, et al.
Published: (2025)
Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi
by: Siyao Chen, et al.
Published: (2026)
by: Siyao Chen, et al.
Published: (2026)
Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
by: Alexander Dömling, et al.
Published: (2025)
by: Alexander Dömling, et al.
Published: (2025)
Development of New Peptidomimetic NADPH Oxidase Inhibitors with Antithrombotic Properties
by: Elisabetta Scalia, et al.
Published: (2024)
by: Elisabetta Scalia, et al.
Published: (2024)
Structure‐Atropisomer Stability Relationship in Selective MCL‐1 Inhibitors
by: Szabolcs Sipos, et al.
Published: (2025)
by: Szabolcs Sipos, et al.
Published: (2025)
From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
by: Mehmet Ali Yucel, et al.
Published: (2024)
by: Mehmet Ali Yucel, et al.
Published: (2024)
Flavonoid‐Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis
by: Florencia Ferraro, et al.
Published: (2024)
by: Florencia Ferraro, et al.
Published: (2024)
Investigating the Ligand‐Binding Properties of N‐arylbenzimidazoles as Novel Elastase Inhibitors
by: Giovanna Pitasi, et al.
Published: (2025)
by: Giovanna Pitasi, et al.
Published: (2025)
Structural Analysis of the Macrocyclic Inhibitor BI‐4020 Binding to EGFR Kinase
by: Tyler S. Beyett, et al.
Published: (2024)
by: Tyler S. Beyett, et al.
Published: (2024)
Macrocyclic Inhibitors Targeting the Prime Site of the Fibrinolytic Serine Protease Plasmin
by: Simon J. A. Wiedemeyer, et al.
Published: (2024)
by: Simon J. A. Wiedemeyer, et al.
Published: (2024)
Similar Items
-
2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors
by: Zheng Ma, et al.
Published: (2025) -
In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
by: Frankie S. Mak, et al.
Published: (2026) -
Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
by: Kelly A. McCarthy, et al.
Published: (2024) -
Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy
by: Gaurav Sheth, et al.
Published: (2025) -
An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
by: Yazhou Wang, et al.
Published: (2026)